 |
|
MONDAY, 8 SEPTEMBER 2008 |
|
|
|
8:00AM-8:40AM |
WELCOME (Simultaneous English/Korean translation provided) Convention Hall DE |
|
Bong-Min Yang PhD, Program Chair, and Professor, School of Public Health, Seoul National University, Seoul, South Korea
Biographical Information
Jang-Moo Lee, President, Seoul National University, Seoul, South Korea
Chris L. Pashos PhD, 2008-2009 ISPOR President, and Vice President & Executive Director, HERQuLES Health Economic Research and Quality of Life Evaluation Services Abt Bio-Pharma Solutions, Inc., Lexington, MA, USA
Biographical Information
Shanlian Hu MD, MSc, 2008-1010 Consortium Executive Committee Chair, and Professor, School of Public Health, Fudan University, Shanghai, China
Biographical Information |
B. Yang
J. Lee
|
C. Pashos
S. Hu
|
|
|
8:40AM-9:00AM |
GUEST PRESENTATION (Simultaneous English/Korean translation provided) Convention Hall DE |
|
President, Health Insurance Review Assessment & Service, Seoul, South Korea
|
|
9:00AM-9:15AM |
BREAK, EXHIBIT & POSTER
PRESENTATION VIEWING Grand Ballroom |
|
|
9:15AM-11:15AM |
FIRST PLENARY SESSION (Simultaneous English/Korean translation provided) Convention Hall DE |
|
EVIDENCE-BASED DECISION MAKING IN ASIA-PACIFIC
HEALTH CARE SYSTEMS OF CHINA MAINLAND, INDIA, JAPAN, SOUTH KOREA, MALAYSIA, PAKISTAN, PHILIPPINES, SINGAPORE, TAIWAN AND THAILAND
A panel discussion on evidence-based health care decision making in the health care systems of the listed countries/areas. The discussion will focus on health technology approval, pricing, reimbursement and financial control policies (drug, medical device & diagnostics). See more information
Moderator/Speaker:
Kenneth KC Lee JP, BSc(Pharm), MPhil, PhD, Professor, School of Pharmacy, Faculty of Medicine, The Chinese University of Hong Kong, Hong Kong, China
Biographical Information |
 |
Panelists:
Rapidly Changing Systems: Thailand, South Korea and Taiwan
Suwit Wibulpolprasert PhD, Senior Advisor on Disease Control, Ministry of Health, Nonthaburi, Thailand
Biographical Information
Tae-Jin Lee PhD, Associate Professor of Health Economics, School of Public Health, Seoul National University, Seoul, South Korea
Biographical Information
Ming-Chin Yang PhD, Associate Professor, Medical Administration Institute, National Taiwan University, Taipei, Taiwan
Biographical Information |
| |
K. Lee |
 |
 |
| S. Wibulpolprasert T. Lee |
| |
 |
| |
M. Yang |
|
Moderately Changing Systems: China mainland, Japan and Singapore
Gordon G. Liu PhD, Professor and Chair, Department of Health Economics and Management, Guanghua School of Management, Peking University, Beijing, China
Biographical Information
Takashi Fukuda PhD, Associate Professor, Department of Health Economics and Epidemiology Research, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan
Biographical Information
Chien Earn Lee PhD, Senior Director, Healthcare Performance Group, Ministry of Health, Singapore
Biographical Information |
|
Gradually Changing Systems: India, Pakistan, Malaysia and Philippines
Urmila Mukund Thatte PhD, DNB, MD, MBBS, Professor and Head, Department of Clinical Pharmacology, Topiwala National Medical College, and BYL Nair Charitable Hospital Mumbai Central, Mumbai, India
Biographical Information
Muhammad Ashar Malik M.Sc. Health Economics (York, UK), Senior Instructor, Department of Community Health Sciences, Faculty of Health Sciences, Medical College The Aga Khan University, Karachi, Pakistan
Biographical Information
Samsinah Hussain PhD, Associate Professor, Head of Department of Pharmacy, University of Malaya, Member of the Drug Control Authority (DCA) and Pharmacy Board, Ministry of Health, Malaysia
Biographical Information
Madeleine R. Valera MD, MScIH (Heidelberg), Senior Vice President for Health Finance Policy and Services Sector, Philippine Health Insurance Corporation, Pasig City, Philippines
Biographical Information |
 |
 |
| U. Thatte |
M. Malik |
 |
 |
| S. Hussain |
M. Valera |
|
| |
|
Respondents:
Sandeep Duttagupta PhD, Regional Director, Asia & Latin America, Global Outcomes Research, Pfizer Inc., New York, NY, USA
Biographical Information
Manny Papadimitropoulos PhD, Director, Health Outcomes Research, Intercontinental Region and Japan, Eli Lilly and Company, Toronto, Ontario, Canada
Biographical Information
Mingliang Zhang PhD, Senior Director, Worldwide Health Economics and Pricing, Johnson and Johnson Pharmaceutical Services, Raritan, NJ, USA
Biographical Information |
 |
 |
| S. Duttagupta |
M. Papadimitropoulos |
| |
 |
| |
M. Zang |
|
|
|
11:15AM-11:30AM |
BREAK, EXHIBIT & POSTER
PRESENTATION VIEWING Grand Ballroom |
|
|
11:30AM-12:30PM |
PODIUM PRESENTATION -
SESSION I |
|
Research from China Swan |
| Moderator: Shanlian Hu MD, MSc, Professor, Training Center for Health Management, School of Public Health, Fudan University, Shanghai, China |
| |
|
| CH1: |
BURDEN OF DIABETES IN CHINA |
| |
Jing L1, Hu S2
1Novo Nordisk (China) Pharmaceuticals Co. Ltd, Beijing, China, 2Fudan University, Shanghai, China |
| |
|
| CH2: |
THE SMOKING EFFECTS ON THE ELDERLY IN CHINA |
| |
Li L1, Chen Q1, Jiang Y2, Jia R3
1Peking University, Beijing, China, 2Peiking University, Beijing, China, 3Stockholm University, Stockholm, Sweden |
| |
|
| CH3: |
ECONOMIC BURDEN OF SMOKING IN CHINA |
| |
Li L1, Chen Q1, Cui X1, Yu J1, Jia R2
1Peking University, Beijing, China, 2Stockholm University, Stockholm, Sweden |
| |
|
| CH4: |
ECONOMIC EVALUATION OF ADJUVANT THERAPY WITH TRASTUZUMAB FOR HER2-POSITIVE BREAST CANCER |
| |
Chen W, Huang Y, Qiao N
Fudan University, Shanghai, China |
| |
|
| Research from India Crane |
| Moderator: Urmila Mukund Thatte PhD, DNB, MD, MBBS, Professor and Head, Department of Clinical Pharmacology, Topiwala National Medical College, BYL Nair Charitable Hospital Mumbai Central, Mumbai, India |
| |
|
| IN1: |
COST ANALYSIS OF TREATING ACUTE MYOCARDIAL INFARCTION IN INDIA |
| |
Kochhar P1, Suvarna V1, Duttagupta S2
1Pfizer India, Mumbai, India, 2Pfizer Inc, New York, NY, USA |
| |
|
| IN2: |
EVALUATION OF CURRENT TREATMENT PRACTICES AND OUTCOMES FOR PATIENTS WITH TYPE 2 DIABETES: PROFILE OF UNCONTROLLED DIABETES PATIENTS TREATED IN A PRIVATE CLINIC IN INDIA |
| |
Morarka A, Davis S, Kochhar P, Suvarna V
Pfizer India, Mumbai, India |
| |
|
| IN3: |
BURDEN OF NEUROPATHIC PAIN IN INDIAN PATIENTS ATTENDING URBAN, SPECIALTY CLINICS: RESULTS FROM A CROSS SECTIONAL STUDY |
| |
Sule N; Kochhar P
Pfizer India, Mumbai, Maharashtra, India |
| |
|
| IN4: |
AVAILABILITY AND PRICE OF TWO INHALATION MEDICINES FOR TREATMENT OF ASTHMA IN DIFFERENT STATES OF INDIA |
| |
Kotwani A
Vallabhbhai Patel Chest Institute, University of Delhi, Delhi, India |
| |
|
Research from Japan White Heron |
| Moderator: Lillian Yu-Jen Wang MS, Market Access Manager, Novartis (Taiwan) Co., Ltd., and Executive Secretary, Taiwan Society for Pharmacoeconomics and Outcomes Research (TASPOR), Taipei, Taiwan |
| |
|
| JA1: |
COST-UTILITY ANALYSIS OF SMOKING CESSATION THERAPY UNDER NATIONAL HEALTH INSURANCE SYSTEM IN JAPAN |
| |
Igarashi A, Fukuda T, Tsutani K
University of Tokyo, Bunkyo, Tokyo, Japan |
| |
|
| JA2: |
ASSESSING ITEMS ON THE SF-8 JAPANESE VERSION FOR THE HEALTH-RELATED QUALITY OF LIFE: A PSYCHOMETRIC ANALYSIS BASED ON THE NOMINAL CATEGORIES MODEL OF ITEM RESPONSE THEORY |
| |
Tokuda Y1, Okubo T2, Ohde S1, Jacobs J3, Takahashi O1, Omata F3, Hinohara S1, Fukui T1
1St. Luke's Life Science Institute, Chuo, Tokyo, Japan, 2Japan Society for the Promotion of Science, Chiyoda City, Tokyo, Japan, 3St. Luke's Life Science Institute, Chuo City, Tokyo, Japan |
| |
|
| JA3: |
COST-EFFECTIVENESS ANALYSIS OF SCREENING FOR IRON-DEFICIENCY ANEMIA IN MIDDLE-AGED WOMEN IN JAPAN |
| |
Sakai M, Shimbo T, Takahashi Y
Research Institute, International Medical Center of Japan, Shinjyuku-ku, Tokyo, Japan |
| |
|
| JA4: |
SAFETY OF OSELTAMIVIR (TAMIFLU®) AS MEASURED BY INCIDENCE OF INJURIES |
| |
Okamoto E
National Institute of Public Health, Wako-shi, Saitama, Japan |
| |
|
| Research from South Korea Flamingo |
| Moderator: Sang-Il Lee MD, PhD, MPH, Professor, Department of Preventive Medicine, College of Medicine, University of Ulsan, Seoul, South Korea |
| |
|
| KO1: |
COST-BENEFIT ANALYSIS OF UNIVERSAL ROTAVIRUS VACCINATION IN KOREA |
| |
Sung Y
Health Insurance Review and Assessment, Seoul, South Korea |
| |
|
| KO2: |
HEALTH-RELATED QUALITY OF LIFE OF COMMUNITY DWELLERS WITH MAJOR CHRONIC DISEASES |
| |
Kang E
Korea Institute for Health and Social Affairs, Seoul, South Korea |
| |
|
| KO3: |
HEALTH STATE UTILITY ASSESSMENT BY EQ5D IN CHRONIC HEPATITIS B PATIENTS IN KOREA |
| |
Lee YR1, Kwon SY2, Lee YS3, Lee JH4, Choi HM1, Lee CH2
1GlaxoSmithKline, Seoul, South Korea, 2Konkuk University, Seoul, South Korea, 3Catholic University of Korea, Bucheon, South Korea, 4Sungkyunkwan University, Seoul, South Korea |
| |
|
| KO4: |
EVALUATION OF COST-EFFECTIVENESS OF SMOKING CESSATION INTERVENTIONS IN KOREA |
| |
Bae JY1, Song HJ1, Joe KH2, Kim CH3, Song HR3, Ryu GC4, Kim DJ5, Lee EK1
1Sook Myung Women's University, Seoul, South Korea, 2Department of Medicine, EulJi University, Seoul, South Korea, 3Family Medicine of Seoul Paik Hospital, Seoul, South Korea, 4Korea Institute for Health and Social Affairs, Seoul, South Korea, 5Catholic University of Korea, Holy Family Hospital, Seoul, South Korea |
| |
|
| Research from Thailand Skylark |
| Moderator: Nathorn Chaiyakunapruk PharmD, PhD, Associate Professor, Department of Pharmacy Practice, School of Pharmacy, Naresuan University, Phitsanulok, Thailand |
| |
|
| TH1: |
BUDGET IMPACT ANALYSIS OF COMPULSORY LICENSING POLICY IMPLIMENTATION ON FOUR CANCER DRUGS IN THAILAND |
| |
Mohara A, Praditsitthikorn N, Kingkaew P, Werayingyong P, Pattanaphesaj J, Yamabhai I, Teerawattananon Y
Health Intervention and Technology Assessment Program (HITAP), Nonthaburi, Thailand |
| |
|
| TH2: |
ECONOMIC COSTS OF ALCOHOL ABUSE IN THAILAND: COST OF LAW ENFORCEMENT AND CRIMINAL JUSTICE |
| |
Yothasamut J, Thavorncharoensap M, Teerawattananon Y, Lertpitakpong C, Thitiboonsuwan K
Health Intervention and Technology Assessment Program (HITAP), Nonthaburi, Thailand |
| |
|
| TH3: |
COST-UTILITY ANALYSIS OF RECOMBINANT HUMAN ERYTHROPOIETIN IN CANCER PATIENTS WITH ANEMIA INDUCED BY CHEMOTHERAPY IN THAILAND |
| |
Roungrong J1, Teerawattananon Y1, Chaikledkaew U2
1Health Intervention and Technology Assessment Program (HITAP), Nonthaburi, Thailand, 2Faculty of Pharmacy Mahidol University, Ratchathewi, Bangkok, Thailand |
| |
|
| TH4: |
COST-EFFECTIVENESS ANALYSIS OF SHIGELLA VACCINE FOR CHILDREN UNDER 5 YEARS OLD IN THAILAND |
| |
Sribundit N1, Riewpaiboon A2, Chaikledkaew U2, Noksakda N3
1Silpakorn University, Muang, Nakornpatom, Thailand, 2Faculty of Pharmacy Mahidol University, Ratchathewi, Bangkok, Thailand, 3Udon Thani Province Health Office, Udon Thani, Udon Thani, Thailand |
| |
|
|
|
12:30PM-2:00PM |
LUNCH, EXHIBIT & POSTER
PRESENTATION VIEWING Grand Ballroom |
|
|
1:00PM-2:00PM |
|
|
The Use of Economic Models in Diabetes
The evaluation of cost-effectiveness and value of medical interventions requires the use of economic models in complex diseases. Diabetes is a chronic disease with many complications. Short-term and long-term complications, as well as co-existing diseases, make the management of this disease challenging. In this symposium we will discuss the challenges and approaches needed for the appropriate use of cost-effectiveness models in diabetes.
|
2:00PM-3:00PM |
|
|
CLINICAL OUTCOMES RESEARCH
W1: META-ANALYSIS METHODS THAT ALLOW FOR COMPARISON OF INTERVENTIONS IN THE ABSENCE OF HEAD-TO-HEAD DATA Swan
Discussion Leaders: Bruce Crawford MA, MPH, General Manager, Asia, Mapi Values, Tokyo, Meguro, Japan; Jeroen P Jansen PhD, Project Manager, Mapi Values, Houten, The Netherlands.
ECONOMIC OUTCOMES RESEARCH
W2: USING LATENT CLASS ANALYSIS IN HEALTH OUTCOMES RESEARCH Skylark
Discussion Leaders: Jeonghoon Ahn PhD, Assistant Professor, University of Southern California, Los Angeles, CA, USA.
HEALTH CARE POLICY DEVELOPMENT USING OUTCOMES RESEARCH
W3: BURDEN OF ILLNESS STUDY FOR DEVELOPING HEALTH POLICY IN ASIA-PACIFIC White Heron
Discussion Leaders: Bong-Min Yang PhD, Professor, School of Public Health, Seoul National University, Seoul, South Korea, South Korea; Shu-Chuen Li Ph, D/MBA, Associate Professor, National University of Singapore, Pharmacy, Singapore, N/A, Singapore; Shanlian Hu MD, MSc, Professor, School of Public Health, Fudan University, Shanghai, China; Q. Chau Tini Nguyen PharmD, AP Director, Sanofi-Aventis, Paris, France, France.
W4: FROM THEORY TO PRACTICE: EXPERIENCES OF SOUTH KOREA HEALTH INSURANCE REVIEW ASSESSMENT AND SERVICE (HIRA) (Speakers at this panel were invited) Flamingo
Discussion Leaders: Sang Moo Lee MD PhD, Consultant EBH team, Health Insurance Review Assessment and Service, Seoul, Korea; So-Young Yi PhD, General Manager, Drug Listing Division, Health Insurance Review and Assessment Service, Seoul, Korea; SeungJin Bae ScD, Senior Researcher, Drug Policy Research Team, Health Insurance Review Assessment and Service, Seoul, Korea |
3:00PM-3:15PM |
BREAK, EXHIBIT & POSTER
PRESENTATION VIEWING Grand Ballroom |
|
|
3:15PM-4:15PM |
|
|
HEALTH POLICY ISSUES
IP1: GAINING ACCESS TO THE ESSENTIAL MEDICINES IN THAILAND THROUGH THE USE OF COMPULSORY LICENSING POLICY: PROS AND CONS (GOOD OR EVIL)? Crane
Moderator: Viroj Tangcharoensathien MD, PhD, Director of International Health Policy Program, Bureau of Policy and Strategy, Nonthaburi, Thailand.
Panelists: Suwit Wibulpolprasert MD, MPH, Senior Advisor on Disease Control, Office of the Permanent Secretary, Ministry of Public Health, Nonthaburi, Thailand; Sripen Tantivess PhD, Researcher, Health Intervention and Technology Assessment Program (HITAP), Nonthaburi, Thailand; TBD, Representative from industry and Pharmaceutical Research and Manufacturer Association (Prema), Bangkok, Thailand.
HEALTH CARE REIMBURSEMENT/COVERAGE ISSUES
IP2: VARIATIONS IN BIOLOGICS ACCESS IN THE ASIA PACIFIC – IMPLICATIONS FOR REIMBURSEMENT POLICIES Skylark
Moderator: Mingliang Zhang PhD, Senior Director, Worldwide Health Economics and Pricing, Johnson & Johnson Pharmaceutical Services, Raritan, NJ, USA.
Panelists: Karen Eggleston PhD, Fellow, Asia-Pacific Research Center, Stanford University, Stanford, CA, USA; Chee Ruey Hsieh PhD, Fellow, Academia SINICA, Taipei, Taiwan.
IP3: ASEAN HARMONIZATION AND IMPROVING DRUG ACCESS: WHERE ARE THE BENEFITS AND RISKS (Speakers at this panel were invited) White Heron
Moderator: Anita Kotwani PhD, Associate Professor, Department of Pharmacology, Vallabhbhai Patel Chest Institute, University of Delhi, Delhi, India
Panelists: Joshua Ramos, Deputy Director, Philippine Bureau of Food and Drugs, Manila, Philippines (invited); Syed Mohamed Aljunid MD, MSc, PhD, FAMM, Professor, Head of Department of Community Health, Faculty of Medicine, University Kebangsaan Malaysia, Kuala Lumpur, Malaysia; Surachat Ngorsuraches PhD, RPh, Head of Pharmacy Administration Department, Faculty of Pharmaceutical Sciences, Prince of Songkla University, Hatyai, Songkla, Thailand.
IP4: EARLY EXPERIENCE IN IMPLEMENTING CONDITIONAL COVERAGE DECISIONS WITH EVIDENCE GENERATION IN THE UK AND SOUTH KOREA CONTEXT: PRACTICAL AND METHODOLOGICAL CHALLENGES (Speakers at this panel were invited) Flamingo
Moderator: Dae-Seog Heo MD, Professor, Department of Internal Medicine, College of Medicine, Seoul National University, Seoul, South Korea
Panelistes: Sang Moo Lee MD. PhD, Consultant EBH Team, Health Insurance Review & Assessment Service, Seoul, South Korea; Kalipso Chalkidou MD, PhD, Associate Director NICE R&D, UK, and Johns Hopkins School of Public Health, USA
USE OF HEALTH ECONOMIC/PHARMACOECONOMIC INFORMATION BY DECISION-MAKERS ISSUES
IP5: PHARMACOECONOMICS AND OUTCOME RESEARCH IN INDONESIA, MONGOLIA AND VIETNAM: IS THIS A PRE-REQUISITE FOR THE NEW DRUG REGULATOR? (Speakers at this panel were invited) Swan
Moderator: Anita Kotwani PhD, Associate Professor, Department of Pharmacology, Vallabhbhai Patel Chest Institute, University of Delhi, Delhi, India
Panelists: Ahmad Fuad Afdhal PhD, Chief Executive Officer, Center for Socio-Economic Studies in Pharmacy, Jakarta, Indonesia; Byambaa Ganbat PhD, Associate Professor and Dean for Graduate Training, Scientific Secretary of Academic Council, Health Sciences University of Mongolia, Ulaanbaatar, Mongolia; Cao Minh Quang, Vice Minister, Vietnam Ministry of Health, Ho Chi Minh City, Vietnam; Jawahar S. Bapna PhD, MD, MB, Professor, Pharmaceutical Management, Indian Institute of Health Management Research, Jaipur, India. |
4:15PM-4:30PM |
BREAK, EXHIBIT & POSTER
PRESENTATION VIEWING Grand Ballroom |
|
|
4:30PM-6:00PM |
SECOND PLENARY SESSION (Simultaneous English/Korean translation provided) Convention Hall DE |
|
DEVELOPING EVIDENCE USING HEALTH TECHNOLOGY ASSESSMENT (HTA)
Activities and achievements of the European Network for Health Technology Assessment (EUnetHTA) and Canadian Agency for Drugs and Technologies in Health (CADTH) will be presented. Issues on how the existing HTAs can be adapted globally will be discussed. Cases of Asian HTA initiatives in Taiwan and South Korea will be introduced.
Moderator:
Isao Kamae MD, DrPH, Professor and Chair, Graduate School of Health Management, Keio University, Tokyo, Japan
Biographical Information |
I. Kamae
|
Speakers:
Harmonize HTA Globally – Activities and achievements of EUnetHTA & CADTH
Finn Boerlum Kristensen MD, PhD, Director & Professor, Danish Centre for Health Technology Assessment, National Board of Health, Copenhagen, Denmark; Adjunct Professor, University of Southern Denmark; Project Leader, European Network for HTA (EUnetHTA)
Biographical Information
Jill M. Sanders PhD, President and CEO, Canadian Agency for Drugs and Technologies in Health (CADTH), Ottawa, ON, Canada
Biographical Information
HTA Initiatives in Asia – Cases of Taiwan and South Korea
Tony Yen-Huei Tarn MS, PhD, Senior Researcher, Health Technology Assessment Task Force, Center for Drug Evaluation, Taipei, Taiwan
Biographical Information
Eui-Kyung Lee PhD, Professor, Graduate School of Clinical Pharmacy, Sookmyung Women’s University, Seoul, South Korea
Biographical Information |
 |
 |
| F. Kristensen |
J. Sanders |
 |
 |
| Y. H. Tarn |
E. Lee |
|
|
6:00PM-7:00PM |
RESEARCH POSTER AUTHOR DISCUSSION HOUR Grand Ballroom |
|
|
6:00PM-8:00PM |
RECEPTION, EXHIBITS & POSTER PRESENTATIONS VIEWING Grand Ballroom |
|
|
7:00PM-8:30PM |
ISPOR Asia-Pacific Medical Device & Diagnostics Council Dinner Meeting (by invitation only) |
|
|
7:00PM-8:00PM |
|
|
VALUE OF ANTIVIRAL TREATMENTS FOR CHRONIC HEPATITIS B
Due to its high prevalence rate, chronic hepatitis B (CHB) is a public health concern in most countries of the Asia-Pacific region. New antiviral treatments have emerged for CHB with different clinical profiles and drug acquisition costs. These new treatments have created issues relating to how to evaluate the value of different antivirals for CHB. This symposium aims to address these issues through review and discussion of current literature on the topic.
|
|
|
7:00PM-8:30PM |
ISPOR Asia-Pacific Medical Device & Diagnostics Council Dinner Meeting (by invitation only) |
|
|
8:30PM-9:30PM |
Asia Consortium Business Meeting (by invitation only) - Swan |
|
|
| |
|
|
|
